Literature DB >> 23337229

Mapping from disease-specific to generic health-related quality-of-life scales: a common factor model.

Guobing Lu1, J E Brazier, A E Ades.   

Abstract

OBJECTIVES: To develop a coherent method for estimating mappings between treatment effects on disease-specific measurement (DSM) instruments and generic health-related quality-of-life (QOL) measures, when both are subject to measurement errors.
METHODS: We identified three properties that must be satisfied for mappings to be logically coherent: invertability, transitivity, and invariance to linear transformation. Of the common regressions, ordinary least squares (OLS), geometric mean (GM), and orthogonal regression, only GM has all these properties, and then only in special cases. We developed a common factor model of how DSM and generic QOL scales are related, and derived expressions for coherent mapping coefficients. We showed that these are equivalent to adjusted forms of OLS or GM regressions. Where cohort data are available on just one DSM and one QOL measure, external data on the reproducibility of the DSM are required. In some circumstances, the mappings can be estimated without external data. We illustrated the estimation of mapping coefficients by using data on EuroQol five-dimensional (EQ-5D) questionnaire, 12-item short form health survey (SF-12) Mental Component Summary, and the Beck Depression Inventory (BDI), from a trial of treatments for depression.
RESULTS: OLS underestimates and GM overestimates mappings from DSMs to generic QOL measures. Mappings estimated by using external data on reliability were similar to those estimated by using internal data, suggesting approximate adequacy of the common factor model.
CONCLUSIONS: Neither OLS nor GM regression, unless corrected, is suitable for estimating mappings between disease-specific and generic QOL scales. OLS systematically underestimates mappings, but it can be adjusted by using external information on test-retest reliability.
Copyright © 2013 International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23337229     DOI: 10.1016/j.jval.2012.07.003

Source DB:  PubMed          Journal:  Value Health        ISSN: 1098-3015            Impact factor:   5.725


  10 in total

1.  Mapping clinical outcomes to generic preference-based outcome measures: development and comparison of methods.

Authors:  Mónica Hernández Alava; Allan Wailoo; Stephen Pudney; Laura Gray; Andrea Manca
Journal:  Health Technol Assess       Date:  2020-06       Impact factor: 4.014

2.  Should linking replace regression when mapping from profile-based measures to preference-based measures?

Authors:  Peter M Fayers; Ron D Hays
Journal:  Value Health       Date:  2014-03       Impact factor: 5.725

3.  Mapping the EORTC QLQ-C30 onto the EQ-5D-3L: assessing the external validity of existing mapping algorithms.

Authors:  Brett Doble; Paula Lorgelly
Journal:  Qual Life Res       Date:  2015-09-21       Impact factor: 4.147

4.  Some comments on mapping from disease-specific to generic health-related quality-of-life scales.

Authors:  Mari Palta
Journal:  Value Health       Date:  2012-10-25       Impact factor: 5.725

5.  Exploring the relationship between EQ-5D, DLQI and PASI, and mapping EQ-5D utilities: a cross-sectional study in psoriasis from Hungary.

Authors:  Emese Herédi; Fanni Rencz; Orsolya Balogh; László Gulácsi; Krisztina Herszényi; Péter Holló; Hajnalka Jókai; Sarolta Kárpáti; Márta Péntek; Éva Remenyik; Andrea Szegedi; Valentin Brodszky
Journal:  Eur J Health Econ       Date:  2014-05-16

6.  Simultaneous synthesis of treatment effects and mapping to a common scale: an alternative to standardisation.

Authors:  A E Ades; Guobing Lu; Sofia Dias; Evan Mayo-Wilson; Daphne Kounali
Journal:  Res Synth Methods       Date:  2015-01-23       Impact factor: 5.273

7.  Simultaneous multioutcome synthesis and mapping of treatment effects to a common scale.

Authors:  Guobing Lu; Daphne Kounali; A E Ades
Journal:  Value Health       Date:  2014-03       Impact factor: 5.725

Review 8.  Review of studies mapping from quality of life or clinical measures to EQ-5D: an online database.

Authors:  Helen Dakin
Journal:  Health Qual Life Outcomes       Date:  2013-09-05       Impact factor: 3.186

9.  Statistical Alchemy: Conceptual Validity and Mapping to Generate Health State Utility Values.

Authors:  Jeff Round; Annie Hawton
Journal:  Pharmacoecon Open       Date:  2017-12

Review 10.  Uptake of methodological advances for synthesis of continuous and time-to-event outcomes would maximize use of the evidence base.

Authors:  Suzanne C Freeman; Alex J Sutton; Nicola J Cooper
Journal:  J Clin Epidemiol       Date:  2020-05-12       Impact factor: 6.437

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.